187 related articles for article (PubMed ID: 22857732)
1. [The 'Myozyme' decision of the Federal Supreme Court of Switzerland and German Law: a constitutional rights and health insurance law perspective].
Huster S; Bohmeier A
Z Evid Fortbild Qual Gesundhwes; 2012; 106(6):443-8. PubMed ID: 22857732
[TBL] [Abstract][Full Text] [Related]
2. [IGeL - a questionable debate].
Schaefer C
Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):540-1. PubMed ID: 22981030
[No Abstract] [Full Text] [Related]
3. [Health services research: essential for allocation decisions - joint statement].
Pfaff H; Abholz H; Glaeske G; Icks A; Klinkhammer-Schalke M; Nellessen-Martens G; Neugebauer EA; Ohmann C; Schrappe M; Selbmann HK; Stemmer R;
Dtsch Med Wochenschr; 2011 Dec; 136(48):2496-500. PubMed ID: 21993809
[No Abstract] [Full Text] [Related]
4. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
5. Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
Gerber-Grote A; Sandmann FG; Zhou M; Ten Thoren C; Schwalm A; Weigel C; Balg C; Mensch A; Mostardt S; Seidl A; Lhachimi SK
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):390-6. PubMed ID: 25444297
[TBL] [Abstract][Full Text] [Related]
6. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
Rogowski WH; Landauer M; John J
Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
[TBL] [Abstract][Full Text] [Related]
7. [Rationing health care by thresholds for clinical benefit and its acceptance by the German population].
Schöne-Seifert B; Friedrich DR; Diederich A
Z Evid Fortbild Qual Gesundhwes; 2012; 106(6):426-34. PubMed ID: 22857730
[TBL] [Abstract][Full Text] [Related]
8. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric psychotherapeutic psychosomatic treatment by the hospital: framework for the development of a multi-sector budget for regional mandatory care].
Kruckenberg P; Beine K; Aderhold V; Bock T; Bührig M; Deister A; Driessen M; Elsässer-Gaismaier HP; Grampp P; Greve N; Heinz A; Heinze M; Heisler M; Küthmann A; Kunze H; Lucht M; Niedermeyer U; Obliers W; Schütze W; Stock M
Psychiatr Prax; 2009 Jul; 36(5):246-9. PubMed ID: 19582663
[No Abstract] [Full Text] [Related]
10. Health resource allocation. A made-in-Canada description.
Noseworthy T
J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053
[No Abstract] [Full Text] [Related]
11. An extreme makeover for the employer's house of health benefits.
Boress LS
J Leg Med; 2011 Jan; 32(1):51-60. PubMed ID: 21391055
[No Abstract] [Full Text] [Related]
12. [Off-label therapy in rheumatology].
Krüger K; Sieper J
Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
[No Abstract] [Full Text] [Related]
13. [Reimbursement of new medical therapy].
Ehlers AP; Wenke A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):849-55. PubMed ID: 21698539
[TBL] [Abstract][Full Text] [Related]
14. Hospital reimbursement incentives: is there a more effective option?--Part II.
Weil TP
J Med Pract Manage; 2013; 28(4):254-6. PubMed ID: 23547503
[TBL] [Abstract][Full Text] [Related]
15. [Abortion using health insurance].
Gritschneder O
Geburtshilfe Frauenheilkd; 1984 Sep; 44(9):604-7. PubMed ID: 6567566
[TBL] [Abstract][Full Text] [Related]
16. ["Deficiencies in the mandatory health insurance system"--possibilities and limits of medical expert assessment].
Mayer ED; Boukamp K; Zink J; Simoes E; Schwoerer P
Gesundheitswesen; 2000 Oct; 62(10):538-46. PubMed ID: 11103565
[TBL] [Abstract][Full Text] [Related]
17. [The "cost reimbursement" trial regulation in mandatory health insurance: results of a survey of participants].
König HH; Seitz R; Arnold M
Gesundheitswesen; 1999 Jan; 61(1):13-9. PubMed ID: 10081181
[TBL] [Abstract][Full Text] [Related]
18. [Should health care be rationed by age? -- Contra].
Marckmann G
Dtsch Med Wochenschr; 2005 Feb; 130(7):351-2. PubMed ID: 15712025
[No Abstract] [Full Text] [Related]
19. Eliminating innovation: how price controls limit access.
Ingram J
J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
[No Abstract] [Full Text] [Related]
20. [Rationing sickness fund benefits by age? -- Pro].
Breyer F
Dtsch Med Wochenschr; 2005 Feb; 130(7):349-50. PubMed ID: 15712024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
